Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed) | RFA DA 22 007

Frequently Asked Questions (FAQs)

What is the funding opportunity?

This opportunity is the NIH Funding Opportunity Announcement (FOA) RFA-DA-22-007, titled "Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed)." It supports mechanistic research on how socioeconomic inequality influences substance use risk, progression, and outcomes.

What is the main purpose of this FOA?

The central goal is to explain how socioeconomic inequality gets "under the skin" by identifying and testing neurocognitive pathways that link unequal social and economic conditions to stages of the substance use trajectory. The focus is on why and how associations emerge, not simply whether inequality correlates with substance use.

What kinds of research questions are encouraged?

Projects are encouraged to investigate brain-based, cognitive, affective, and related processes that translate lived social conditions into changes in behavior and health. The FOA emphasizes mechanistic evidence that clarifies causal pathways and identifies actionable targets that can inform prevention strategies and policy-relevant interventions (even if the study itself is not an intervention trial).

What does "mechanistic" mean in the context of this opportunity?

Mechanistic research, as emphasized here, means specifying and testing pathways (for example, neurocognitive processes) that explain how socioeconomic inequality leads to changes in substance use vulnerability and progression. The goal is to isolate the processes that connect exposures (inequality-related conditions) to outcomes (substance use behaviors and trajectories).

Which parts of the substance use trajectory are relevant?

The FOA explicitly references multiple stages, including early initiation, escalation, transition to substance use disorder, patterns of relapse, and recovery. Applications can focus on one or more stages as long as the mechanistic link to socioeconomic inequality is clearly articulated and tested.

What types of inequality-related conditions does the FOA mention?

The announcement points to conditions such as chronic adversity, resource scarcity, neighborhood disadvantage, discrimination, and instability in housing, employment, and education. These can be conceptualized and measured at individual, family, neighborhood, or structural levels.

What neurocognitive mechanisms are specifically highlighted?

Examples named in the FOA include cognitive control, reward processing, stress responsivity, decision-making, learning, emotion regulation, threat detection, and impulsivity. Other related functions may also be appropriate if they are plausibly shaped by inequality-related experiences and can be linked to substance use outcomes.

Is the FOA looking for studies that only document disparities?

No. The FOA emphasizes that the desired end product is not just documentation of disparities, but mechanistic evidence pinpointing the processes through which inequality exerts its effects on substance use vulnerability and progression.

What research designs and analytic approaches are suggested for mechanistic inference?

The FOA indicates that projects should use rigorous measurement and analytic strategies capable of isolating mechanisms. Examples mentioned include mediation models, longitudinal designs, quasi-experimental approaches, natural experiments, or other designs suitable for mechanistic inference without running a clinical trial.

What grant mechanism is used?

This is an NIH discretionary grant using the R01 mechanism, which generally supports a substantial, multi-year research plan.

What does the R01 mechanism imply for project scope?

The FOA signals an expectation for a substantial, well-powered, multi-year study grounded in strong theory, with rigorous measures and analyses designed to test mechanistic pathways. While the listing does not specify an award ceiling, it notes that R01s generally involve relatively larger, multi-year budgets than smaller exploratory grants, with final amounts depending on institute priorities, project scope, and negotiated budgets.

Are clinical trials allowed under this FOA?

No. The FOA is explicitly labeled "Clinical Trial Not Allowed," meaning the proposed work must not include a clinical trial as defined by NIH.

What does "Clinical Trial Not Allowed" mean for study activities?

Projects must not prospectively assign participants to an intervention to evaluate its effects on health-related outcomes. The emphasis should remain on mechanistic understanding rather than testing treatment or prevention programs.

Can applicants still conduct human subjects research?

Yes. The FOA indicates that human subjects research is allowed, including observational, longitudinal, and laboratory-based studies, as long as the project stays within non-trial parameters and complies with human subjects protections.

Are neurocognitive assessments and tools permitted?

Yes. The FOA notes that researchers can incorporate neurocognitive assessments and tools commonly used for mechanistic work, as long as they fit within the "no clinical trial" constraints and meet human subjects requirements.

What is the CFDA number associated with this opportunity?

The CFDA number listed for this opportunity is 93.279.

When was this opportunity created, and what is the original closing date?

The listing states the opportunity was created on May 24, 2021, and the original closing date listed is October 14, 2021.

Does the listing specify the number of expected awards or a maximum award amount?

No. The provided listing does not specify an award ceiling or the number of expected awards.

Who is eligible to apply?

Eligibility is broad and includes a wide range of U.S. organizations, including state, county, and local governments; special districts; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; and Native American tribal organizations that are not federally recognized tribal governments.

Are nonprofits eligible, including those without 501(c)(3) status?

Yes. The FOA lists nonprofit organizations as eligible whether or not they have 501(c)(3) status.

Are for-profit organizations eligible?

Yes. The FOA lists for-profit organizations (other than small businesses) as eligible, and it also lists small businesses as eligible.

Which institutions serving specific populations are highlighted as eligible?

The FOA highlights interest in participation from organizations serving populations often disproportionately affected by socioeconomic inequality and substance-related harms. Examples listed include Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); and Tribally Controlled Colleges and Universities (TCCUs).

Are faith-based and community-based organizations eligible?

Yes. The FOA includes faith-based or community-based organizations among eligible applicants.

Are U.S. territories or possessions eligible?

Yes. The FOA includes U.S. territories or possessions among eligible applicants.

Are foreign (non-U.S.) entities eligible?

Yes. The FOA includes non-domestic (non-U.S.) entities (foreign organizations) among eligible applicants.

Are Indian/Native American tribal governments that are not federally recognized eligible?

Yes. The FOA explicitly includes Indian/Native American Tribal Governments that are not federally recognized, and it also includes Native American tribal organizations that are not federally recognized tribal governments.

What would a competitive application generally need to demonstrate?

Based on the FOA description, competitive applications would be expected to: (1) connect well-specified measures of social inequality (individual, family, neighborhood, or structural) to (2) carefully selected neurocognitive constructs, and (3) link those constructs to meaningful points along the substance use trajectory using rigorous designs and analyses suited to mechanistic inference.

Is the FOA intended to support policy or prevention relevance even without testing an intervention?

Yes. The FOA frames mechanistic identification as a way to inform prevention strategies and policy-relevant interventions, even when the proposed research itself is not a prevention or treatment trial.

Which activity categories does this grant fall under?

The listing describes it as falling within education and health activity categories.